A harrowing back injury in 2025 left Greek tennis sensation Stefanos Tsitsipas at a crossroads after a tough defeat at the US Open. His inability to walk for weeks prompted a deep reflection on his ...

The Greek tennis player and former world number three opened his heart at a press conference ahead of the start of the United Cup in Perth, Australia Stefanos Tsitsipas has revealed that he seriously ...

Maria Sakkari has vociferously backed Stefanos Tsitsipas to rediscover his finest form in 2026 and join Carlos Alcaraz and Jannik Sinner at the summit of the ATP Tour's singles rankings. Tsitsipas, a ...

Ex-World No 3 admitted situation reached a breaking point after his US Open defeat Greece’s Stefanos Tsitsipas hits a forehand return to Germany’s Daniel Altmaier during their men's singles second ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ: AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with ...

The new indication is relatively rare in the U.S., but pricing is substantial, and the need for the treatment is significant. The positive update turns the company's fortunes around after a ...

Investing.com -- Agios Pharmaceuticals (NASDAQ:AGIO) stock fell 7% after the company announced that the U.S. Food and Drug Administration (FDA) has not yet issued a regulatory decision on its ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients ...

Stefanos Tsitsipas's mother revealed the tennis couple's breakup stemmed from injuries and the pressures of their demanding careers. Despite initial hopes and a brief reconciliation, the long-distance ...